Clinical Trial Update: Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a genomic biomarker–selected umbrella neoadjuvant approach for high-risk localized prostate cancer. It is currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: University of British Columbia | Conditions: Prostate Cancer | Phase 2 | Status: RECRUITING